The toxic metal lead is a widespread environmental health hazard that can adversely affect human health. In an effort to better understand the cellular and molecular consequences of lead exposure, we have employed cDNA microarrays to analyze the effects of acute lead exposure on large-scale gene expression patterns in immortalized rat astrocytes. Our studies identified many genes previously reported to be differentially regulated by lead exposure. Additionally, we have identified novel putative targets of lead-mediated toxicity, including members of the family of calcium/phospholipid binding annexins, the angiogenesis-inducing thrombospondins, collagens, and tRNA synthetases. We demonstrate the ability to distinguish lead-exposed samples from control or sodium samples solely on the basis of large-scale gene expression patterns using two complementary clustering methods. We have confirmed the altered expression of candidate genes and their encoded proteins by RT-PCR and Western blotting, respectively. Finally, we show that the calcium-dependent phospholipid binding protein annexin A5, initially identified as a differentially regulated gene by our microarray analysis, is directly bound and activated by nanomolar concentrations of lead. We conclude that microarray technology is an effective tool for the identification of lead-induced patterns of gene expression and molecular targets of lead. © 2001 Academic Press Key Words: metal; toxicity; microarray; toxicogenomics.
The natural properties of the heavy metal lead have made it an indispensable part of numerous industrial procedures. For decades, lead was used in automotive gasoline and household paints (Haar, 1975; Mushak and Crocetti, 1989; Goyer, 1996; Romieu et al., 1997; Mielke and Reagan, 1998) . Although use of lead in these products was made illegal in the United States decades ago, lead is still used in numerous industrial procedures (Johnson, 1998) . Lead is used despite the fact that it is widely known to cause learning disabilities, behavioral abnormalities, and death in humans. As a result, lead is one of the most widely prevalent environmental causes of preventable neurological disorders (Landrigan and Todd, 1994) .
Approximately 8.9% of children in the United States alone have blood-lead levels in excess of the 10 g/dL (ϳ0.5 M) threshold determined to be "concerning" by the Centers for Disease Control (Centers for Disease Control, 1991; Goldstein, 1992; Needleman, 1994 Needleman, , 1998 Bressler et al., 1999) . Numerous bodily systems including the reproductive, nervous, gastrointestinal, immune, renal, cardiovascular, skeletal, muscular, and hematopoetic systems are affected by lead poisoning (Landrigan and Todd, 1994) . Symptoms of chronic low-level lead exposure include learning disorders, IQ reduction, hyperactive behavior, ataxia, and convulsions (Needleman et al., 1990; Bressler and Goldstein, 1991; Finkelstein et al., 1998) . Blood-lead levels of 60 g/dL (ϳ3 M) or more can cause acute symptoms such as colic, headache, cramps, muscle weakness, depression, coma, and death (Johnson, 1998) . The diverse effects of lead on a range of bodily systems suggests that lead affects the normal activity of numerous proteins.
In an attempt to understand the clinical effects of lead poisoning, the cellular and molecular effects of lead have been studied during the past few decades. Lead primarily acts by competing with endogenous cations on protein binding sites. In particular, lead can substitute for both calcium and zinc in numerous proteins (Goering, 1993; Goldstein, 1993; Simons, 1993; Zawia et al., 1998) . This substitution can further alter the normal functioning of these proteins and thus can alter cellular pathways and induce aberrant gene transcription (Zhu and Thiele, 1996; Bouton and Pevsner, 2000b) . Examples of the alteration of the binding characteristics of the calcium-binding proteins include protein kinase C (PKC; Markovac and Goldstein, 1988; Goldstein, 1993; Bressler et al., 1999) , synaptotagmin I (Bouton et al., 2001) , and calmodulin (Habermann et al., 1983; Goldstein and Ar, 1983; Fullmer et al., 1985; Sandhir and Gill, 1994a,b,c; Ouyang and Vogel, 1998) . Low nanomolar concentrations of lead can induce phospholipid binding of the synaptic vesicle protein synaptotagmin I and inhibit the binding of synaptotagmin I to its binding partner syntaxin (Bouton et al., 2001) . These alterations in the binding characteristics of synaptotagmin I by lead may partially account for the effects of lead on neurotransmitter release (Manalis et al., 1984) .
Previous studies have demonstrated that the expression of numerous genes can be altered by lead (Bouton et al., 2000b) . The rat septohippocampal cholinergic system displays a selective sensitivity to lead poisoning that may be due in part to alterations in the transcriptional regulation and enzymatic activity of choline acetyltransferase (ChAT; Bielarczyk et al., 1994 Bielarczyk et al., , 1996 Tian et al., 1996 Tian et al., , 2000 . Differential regulation of mRNA expression of the N-methyl D-aspartate (NMDA) subunit genes has also been observed following lead-exposure (Guilarte, 1997) . In some cases, the alteration of the activity of some calcium-binding proteins by lead may lead to feedback regulation of the transcription of the mRNA transcripts corresponding to those genes. Alternatively, the perturbation of the activity of PKC by lead can cause altered transcriptional regulation of numerous mRNA transcripts that are regulated by PKC. Examples include fos and jun (Janknecht et al., 1995; Foletta, 1996; Pennypacker et al., 1997; Kim et al., 1997 Kim et al., , 2000 Chakraborti et al., 1999) , sialyltransferase (Davey and Breen, 1998) , glial fibrillary acidic protein (GFAP) (Stoltenburg et al., 1996; Zawia and Harry, 1996; Harry et al., 1996) , glutathione S-transferase P (GST-P) (Suzuki et al., 1996) , vascular endothelial growth factor (VEGF) (Hossain et al., 2000) , and neuromodulin Zawia and Harry, 1996; Harry et al., 1996; Pennypacker et al., 1997) . The aberrant transcriptional activation of numerous mRNA transcripts can also be caused by the binding of lead to zinc-finger nucleotide binding proteins (Berg, 1990; Zawia and Harry, 1996; Berg and Godwin, 1997; Zawia et al., 1998; Hanas et al., 1999; Payne et al., 1999) . Finally, lead can alter the activity of zinc-dependent enzymes such as aminolevulinic acid dehydratase (Rocha et al., 1995; Bergdahl et al., 1997; Warren et al., 1998) and carbonic anhydrase (Goering, 1993; Choi and Koh, 1998) .
Considering the broad effects of lead, we hypothesized that large-scale gene expression profiling might lead to the identification of novel gene expression patterns perturbed by lead. Identification of these patterns would provide a large-scale view of the perturbation of cellular systems by acute lead poisoning and suggest certain proteins as putative novel molecular targets of lead poisoning. Therefore, we employed two different but complementary types of cDNA microarrays to detect differential gene expression in astrocyte cell cultures when treated with 10 M lead for 24 h. Astrocytes, along with endothelial cells, comprise the blood-brain barrier. Lead is known to increase the permeability of the blood-brain barrier and can inhibit in vitro astrocyte-endothelial interactions relevant to brain microvessel development (Laterra et al., 1992) . These effects may contribute to the encephalopathy seen at a clinical level following high-level lead exposure, especially in children (Clasen et al., 1973; Goldstein et al., 1974; Press, 1977) . Therefore, astrocytes are an important cellular target of lead (Tiffany-Castiglioni, 1993) .
We recently reported that VEGF was one of the most differentially regulated genes identified in a cDNA microarray study of lead-exposed astrocytes (Hossain et al., 2000) . VEGF is an angiogenesis regulator that functions in the response of the blood-brain barrier to numerous types of insult (Ferrara and Henzel, 1989; Leung et al., 1989; Bartholdi et al., 1997; Cheng et al., 1997) . The lead-induced up-regulation of VEGF initially identified by microarray analysis was confirmed at the RNA level by Northern blotting and at the protein level by Western blotting. Further experimentation demonstrated a requirement for PKC-⑀ activation for the up-regulation of VEGF by lead. During these studies we conducted extensive tests to determine both an optimal concentration range and effective time course for the treatment of the astrocytes cell cultures with lead to determine the 10 M lead concentration and 24-h time course used in the experiments reported herein.
In the present study we have confirmed as proof of principle the differential regulation of many genes previously reported to be affected by lead. These genes include VEGF, as described above, GFAP, and HSP70. In addition, we have identified the differential expression of numerous novel putative targets of acute lead treatment. We have applied the independent methods of RT-PCR and Western blotting in order to confirm the differential regulation of certain genes and proteins. We have used two complementary clustering methods to distinguish between lead-treated and two types of control-treated astrocytes solely based upon gene expression patterns detected in our microarray data. Additionally, we have employed bioinformatic methods in order to identify the coordinate regulation of groups of functionally related genes. Finally, based on our microarray results, we hypothesized that a specific protein, annexin A5, may be a molecular target of lead. We tested that hypothesis and demonstrated a direct effect of nanomolar concentrations of lead on the phospholipid binding characteristics of the annexin A5 protein.
MATERIALS AND METHODS
Clontech cDNA microarrays. Immortalized rat astrocytes, grown in 10-cm culture dishes to 80 -90% confluency, were exposed to either 10 M lead acetate (lead), 10 M sodium acetate (sodium), or no treatment (control) for 24 h. Microscopic analysis of the cells before and after treatment was conducted. There was no discernable difference in the morphology or cell number between the lead versus control or sodium-treated astrocytes (data not shown), suggesting that the lead treatment did not cause nonspecific cytotoxicity. Furthermore, previous studies have demonstrated that astrocytes can withstand exposure to lead concentrations similar to those used here (TiffanyCastiglioni, 1993) without detrimental affects to their viability. Total cellular RNA was extracted from the cells following treatment using RNeasy isolation kit (Qiagen) according to the manufacturer's protocol. Poly(A ϩ ) RNA was isolated from total cellular RNA samples, reverse transcribed in the presence of [ 32 P]dATP to generate radiolabeled cDNA probe, and purified using Chromaspin-200 DEPC H 2 O column chromatography according to the Atlas Pure RNA labeling protocol (Clontech). Clontech Neuroarray microarrays, repre-senting 588 human neuron-and astrocyte-related genes, were hybridized with 32 P-labeled cDNA probes according to the manufacturer's instructions. The blots were exposed to a phosphorimaging screen at room temperature overnight and were visualized by phosphorimaging using Bio-Image analyzer BAS 2500 (Fujifilm).
Hybridized dot intensities on the microarrays were quantified using Clontech AtlasImage software. Normalization of the Clontech data was performed by subtracting the global background value of each microarray (calculated by AtlasImage) from the intensity value for each gene and then dividing the background-subtracted intensity value for each gene by the average intensity of all of the genes on that microarray. Average normalized intensity values were calculated for all genes derived from each microarray. Ratio values were calculated by dividing the average normalized intensity value for a given gene from one condition (e.g., lead) by the average normalized intensity value of that same gene from a different condition (e.g., sodium). Positive and negative signs were arbitrarily assigned to the ratio expression values (i.e., positive equals up-regulated in lead versus sodium and negative equals down-regulated in lead versus sodium). Two-tailed Student's t test p values were calculated for each gene by comparing the normalized intensity values derived from the four lead-treated cell samples against the normalized intensity values derived from either the four control-treated (t test PvC), the three sodium-treated cell samples (t test PvN), or the seven control and sodium samples combined (t test PvAll). Significantly differentially regulated genes were defined as those genes that had a normalized ratio intensity value of Ն1.8, a Student's t test PvAll p value of Ͻ0.05, and a Student's t test PvC or PvN (or both) p value of Ͻ0.05. Table 1 was compiled by integrating those genes that met these strict significance criteria across both the lead versus control and lead versus sodium measurements.
Incyte cDNA microarrays. cDNA for two Incyte UniGEM V microarrays, representing 9182 human genes with a wide variety of functions, was prepared from RNA samples. The RNA samples were derived from four independent preparations per condition of lead, sodium, or control astrocyte cultures yielding two pools of lead-exposed total RNA, one pool of sodium treated total RNA, and one pool of nontreated total RNA. Poly(A ϩ ) RNA was purified from the total RNA pools with the Oligotex kit (Qiagen) and quantified with the RiboGreen RNA Quantitation kit (Molecular Probes) according to the manufacturer's instructions. The four Poly(A ϩ ) RNA samples were sent to Incyte for further processing and hybridization to two UniGEM V microarrays. Data for the two Incyte microarrays were analyzed using Incyte GEMtools software.
Incyte provides intensity values for both the Cy3 (P1) and Cy5 (Balanced P2) signals derived from a microarray. A "balanced ratio expression" value is also provided in which, in a manner similar to the Clontech ratio expression values, up-regulation in one condition versus another condition is arbitrarily given a positive sign and down-regulation of that condition versus the other condition is arbitrarily given a negative sign. As in the Clontech data, in the Incyte data a positive value means up-regulation in lead-exposed samples and a negative value means down-regulation. A significantly, differentially regulated gene on the Incyte microarrays was defined as any gene having an absolute ratio expression value of Ն1.8. This cutoff was based upon extensive quality control experiments performed by Incyte (http://www.incyte.com/reagents/gem/GEM_Validation.pdf).
In order to analyze the coordinated regulation of gene families the set of 17,678 gene ratio expression values derived from both of the Incyte microarrays was cross-referenced with the entire SWISS-PROT database (http:// expasy.proteome.org.au/sprot/) using the DRAGON database (Bouton and Pevsner, 2000a) to annotate the gene expression set with SWISS-PROT keywords. The resulting annotated data set was visualized using the DRAGON Families tool (Bouton and Pevsner, submitted for publication http://pevsnerlab.kennedykrieger.org/dragon.htm). To further investigate the two families that were identified in the DRAGON Families analysis, the set of 17,678 gene ratio expression values was integrated with all possible "default hierarchy nodes" provided by Incyte GEMtools software. The distributions of gene expression values present in each of the resulting subsets of genes were compared against the distribution of all 17,678 gene expression values using a 2 analysis in Microsoft Excel. A set of strict criteria was employed to identify significantly differentially regulated gene families. A significant family (1) had to have at least 20 gene expression measurements; (2) at least 3 of those measurements had to have an absolute value of Ն1.8; (3) at least 10 of those measurements had to be in the same direction; and (4) the family had to have a 2 p value of less than 0.0001 as compared to the distribution of all 17,678 gene measurements.
RT-PCR.
Primers used were as follows: Chloride channel 3 (CLC3): forward, 5Ј-GCA TTT ATG AAG CAC ACA TCC-3Ј reverse, 5Ј-GTT TGC CGT CTG GGC CAT ATG-3Ј; phospholipase A2 (PLA2): forward, 5Ј-GCT CTA GAG CCA CCA TGC AGC ACA TAA TAG TGG AAC AC-3Ј reverse, 5Ј-CCC CCC GGG TCA CTC TCC CAC CTT CAT AGA AGA-3Ј; glyceraldehyde-3-phosphate dehydrogenase (GAPDH): forward, 5Ј-ACC ACC ATG GAG AAG GCT GG-3Ј reverse, 5Ј-CTC AGT GTA GCC CAG GAT GC-3Ј; annexin 5: proprietary Clontech primer, sequence unavailable; and creatine transporter 1 (CT1): proprietary Clontech primer, sequence unavailable.
cDNA was generated from the same 12 RNA samples used on both the Clontech and Incyte microarrays using the SuperScript II Reverse Transcriptase kit (Life Technologies). A Lightcycler PCR thermo-cycler (Roche) was used to perform PCR reactions in order to monitor the linear range of gene product amplification in real-time. Reactions were stopped while amplification of the gene product was in the linear range and a melting temperature for each product was calculated in order to determine specificity of the PCR reaction (data not shown). PCR gene products were electrophoresed on agarose gels and quantitated using Scion Image software (www.scion.com). Band intensities measured for each gene product were normalized by dividing each intensity value by the intensity value of a corresponding GAPDH band amplified from the same cDNA sample.
Western blotting. Rat astrocytes were grown to 80 -90% confluency in 10-cm petri dishes and the cytosolic fraction of Dounce homogenates was collected by differential centrifugation as previously described (Bouton et al., 2001) . These cells were independent of those used in the preparation of RNA for microarray hybridization and RT-PCR reactions. Briefly, cells were detergent-solubilized in Buffer A (50 mM Hepes, 150 mM NaCl, pH 7.4) containing 0.5% Triton X-100. The nuclear fraction was separated by centrifugation at 10,000g for 15 min. The supernatant was centrifuged at 100,000g for 20 min in order to isolate the cytosolic fraction. Equivalent amounts of cytosolic fraction were loaded on 10% SDS-PAGE, electrophoresed, and transferred to nitrocellulose. Ponceau S staining of the blots confirmed proper transfer and equal loading of protein lanes. Antibodies specific for annexin 1 (Transduction Laboratories), annexin 5 (StressGen), MARCKS (Upstate Biotechnology), and syntaxin 1 (Sigma) were incubated with replicate nitrocellulose blots overnight at 4°C. The blots were washed three times, 10 min each in PBS-T and incubated with appropriate peroxidase-conjugated secondary antibody. Three 10-min washes in PBS-T were followed by incubation in ECL (Amersham Pharmacia) and exposure to radiographic film (Kodak X-OMAT AR). Protein band intensities were quantitated using Scion Image software. Band intensities were normalized by dividing each specific intensity value by corresponding intensity values measured from a nonspecific band present across all blots and localized to each gel lane as visualized by Ponceau S staining (data not shown).
Annexin A5/phospholipid binding assay. A his6-tagged fusion in the pET22b prokaryotic expression vector containing the entire open reading frame of annexin A5 was obtained from the laboratory of Dr. Mark Schlissel.
The annexin A5 open reading frame was amplified from the pET22b construct using PCR primers with sequences 5Ј-TCG CCA TGG CAC AGG TTC TCA G-3Ј and 5Ј-CGC AAG CTT GTC ATC TTC TCC ACA GAG-3Ј. The resulting PCR product was cloned into the pGEX-KG expression vector using HindIII and NcoI restriction enzymes. The resulting plasmid construct was heat-shock transformed into DH10B Escherichia coli bacteria. Preparation of recombinant GST-tagged annexin A5 protein was by growth and lysis of the E. coli bacteria followed by precipitation with glutathione sepharose beads (Pharmacia). Thrombin cleavage for 1 h at room temperature was used to dissociate the protein from its GST tag. SDS-PAGE and Coomassie blue staining were used to confirm the size, purity, and concentration of the protein (Fig. 8A ).
Tritiated phospholipid liposomes composed of lipid bilayers were prepared as previously described (Davletov and Südhof, 1993; Chapman and Jahn, 1994; Bouton et al., 2001) . Briefly, brain phosphatidylserine (PS) (Avanti Polarlipids), brain phosphatidylcholine (PC) (Avanti Polarlipids), and [ 3 H]PC (Amersham) were stored in chloroform at Ϫ80°C. Glass capillary tubes were used for measurement of appropriate volumes of phospholipid. Seventy-five percent PC, 25% PS and approximately 0.1 mCi/ml of [ 3 H]PC were mixed and dried under a stream of nitrogen gas. The dried lipid mixture was resuspended in Buffer A and probe sonicated for 30 s. Centrifugation for 1 min at 5000g precipitated large phospholipid aggregates, yielding a supernatant containing a suspension of liposomes.
Phospholipid binding assays were performed as described (Davletov and Südhof, 1993; Chapman and Jahn, 1994; Bouton et al., 2001) . Chelator types and concentrations were calculated based on chelator-cation dissociation constants from Martell and Smith (1989) with the software program "Chelator" (Schoenmakers et al., 1992) . Chelators used were EGTA, nitrilotriacetic acid (NTA), and N-benzyliminodiacetic acid (N-BIDA).
[
3 H]Phospholipid liposomes, thrombin-cleaved recombinant annexin A5 protein, annexin A5 antibody (A. G. Scientific Inc.), Protein-G Sepharose (Pharmacia), and calculated concentrations of chelator and CaOAc or PbOAc were brought to a total volume of 100 l with Buffer A. Reactions were incubated for 1 h at 4°C. Samples were washed three times in 500 L per wash with incubation buffer and then resuspended in Ecolite scintillation fluid. Levels of radioactivity in each sample were determined by liquid scintillation spectroscopy. Curves were fit to the data with the equation
as previously described by Tomsig and Suszkiw (1995) . R max is the maximum amount of phospholipid precipitated, [M] is the concentration of metal, and EC50 is the concentration of metal at which binding is half-maximal. The amount of radioactive isotope in 10 l of labeled phospholipid was measured for each experiment. All experiments were performed in triplicate. In order to normalize our data, background levels of radioactivity (amount of radioactivity precipitated by annexin A5 protein in the absence of cations) were subtracted from all measurements. The amount of radioactivity precipitated in each condition was then multiplied by 10,000 and divided by the total amount of radioactivity present in 10 l of phospholipid liposomes.
RESULTS

Clontech Microarrays
Twelve Clontech Neuroarrays, representing 588 genes that encode proteins involved in neuronal and astrocytic processes, were hybridized with cDNA prepared from 12 independent samples derived from quadruplicate cell cultures treated with three different conditions: no treatment (control), 10 M sodium acetate (sodium) as a control for acetate, or 10 M lead acetate (lead). Data from one of the sodium blots were discarded due to the substandard quality of the blot hybridization, leaving data from 11 arrays (4 control replicates, 3 sodium replicates, and 4 lead replicates). Of the 588 genes represented on the Clontech Neuroarrays, 418 were detected according to predefined criteria (see Materials and Methods) on at least one array. This set of 418 genes was used for all further Clontech data analyses. Normalized expression values were calculated as described under Materials and Methods.
Scatter plots of the log average lead versus either log average control (Fig. 1A) or sodium (Fig. 1B) normalized intensity values indicated even distributions of gene intensity values between the lead and the two control data sets. Strict conditions were applied in order to identify those genes that were significantly differentially regulated among the 418 genes (Figs. 1A and 1B open circles). These conditions were, first, a ratio expression value of Ն1.8 (chosen due to its correspondence with the ratio expression value used with the Incyte data) and, second, a Student's t test value of p Ͻ 0.05 calculated across replicate measurements from each condition for every gene. Ninety-four of 418 genes (22%) met these criteria in the lead versus control data. Of those 94 genes, 80 were up-regulated (85%) and 14 were down-regulated (15%). Sixty of 418 genes (14%) met these criteria in the lead versus sodium data. Of those 60 genes, 48 were up-regulated (80%) and 12 were down-regulated (20%). Forty-four genes were shared across these two sets of genes (Table 1) . Of those 44 genes, 36 were up-regulated (82%) and 8 were down-regulated (18%). Figure  2 displays the average normalized expression values and hybridized dots from the 11 microarrays for a representative set of 18 genes.
FIG. 1.
Average intensity values were calculated from replicate microarrays hybridized with cDNA derived from astrocytes treated with three different conditions. Scatter plots of the log values of averages were plotted in two graphs, comparing lead-versus control-treated cells (A) and lead-versus sodium-treated cells (B). Significantly differentially regulated genes (open circles) were identified as those genes with both a ratio expression value Ն1.8 and a Student's t test value of p Ͻ 0.05 (see Materials and Methods).
Various clustering techniques have been employed extensively in the analysis of microarray data in order to identify similarities in gene expression patterns across entire data sets. We clustered the Clontech data using two complementary methods to test whether the gene expression pattern caused by lead treatment was distinguishable from control or sodium treatment. The data for the 418 detected genes were imported into both the Cluster/Treeview (http://rana.lbl.gov/EisenSoftware.htm) and Partek (www.partek. com) analysis software packages for clustering analysis. Using Cluster/Treeview Chu et al., 1998; Alizadeh et al., 2000) , a hierarchical clustering tree of the normalized intensity values for each of the 11 microarrays was generated. All four of the lead-treated data sets were clustered away from both the sodium and control data sets. As expected, there was not a clear distinction between the control and sodium data sets (Fig. 3A) . As a complementary form of analysis, the Clontech data were im- 
FIG. 3. (A)
The intensity values of 418 genes from 11 Clontech microarrays (C1-4, N2-4, and P1-4 were clustered using a centered hierarchical clustering algorithm in Cluster. Treeview was used to visualize the clustered data. (B) Principal components analysis (PCA) of the 11 Clontech microarray data sets. Each dot represents all of the data (418 genes) derived from one microarray. The color of each dot (yellow, lead; green, sodium; and red, control) represents the treatment condition for the sample applied to that microarray. ported into the Partek data analysis software package and clustered using principal components analysis (PCA). Proximity in PCA space is indicative of similarity of gene expression patterns between microarray data sets (Gnanadesikan, 1977) . In a manner similar to the hierarchical clustering method, the four lead samples were separated from both the control and the sodium samples across the first principal component, which accounted for 87.3% of the variance in the data (Fig. 3B) . Furthermore, the control and sodium representations in PCA space were intermixed, indicating less difference between them.
Incyte Microarrays
We obtained additional gene expression data using Incyte UniGEM V microarrays. These microarrays contain genes with a wide range of cellular functions. The expression of 9182 genes was analyzed on two fluorescence-based microarrays using pooled cDNA samples derived from the same RNA as that used on the Clontech Neuroarrays. On one array a pooled control-treated cDNA sample was compared against a pooled lead-exposed cDNA sample (PvC). On the other array a pooled sodium-treated cDNA sample was compared against a replicate, pooled lead-exposed cDNA sample (PvN). Scatter plots for the log intensity values derived from the PvC (Fig. 4A) and PvN (Fig. 4B ) data sets provide a graphical representation of significantly differentially regulated genes in the two data sets. The "balanced differential expression" value (hereafter referred to as a "ratio expression value") provided by Incyte was used as the measure of differential regulation for each gene. An absolute ratio expression value cutoff of Ն1.8 was set (see Materials and Methods). On the PvC array, 77 of 8927 genes (0.9%) had an absolute ratio expression value of Ն1.8. Of those 77 genes, 48 were up-regulated (62%) and 29 were down-regulated (38%). On the PvN array, 179 of 8751 genes (2%) had an absolute ratio expression value of Ն1.8. Of those 179 genes, 113 were up-regulated (63%) and 66 were downregulated (37%). Presumably the lower percentage of significantly differentially regulated genes on the Incyte arrays as compared to the Clontech Neuroarrays was due to the fact that the Incyte arrays are not specific to neuronal and astrocytic genes. Fifty-two genes (0.3% of all genes) were common between the two Incyte data sets (Table 2) . Of those 52 genes, 34 were up-regulated (65%) and 18 were down-regulated (35%). Of the 418 genes in the Clontech data set, 282 were also represented on the Incyte microarrays. Of these 282 genes, ϳ80% were expressed in the same direction across the Clontech and Incyte microarrays, indicating substantial correlation between the two data sets. Of these, the most significantly different genes shared across both Clontech and Incyte arrays were neuron specific gene 1 (NSG1), heat shock protein 70 (HSP70), chloride channel 3 (CLC3), and lumican.
In an attempt to identify the coordinate regulation of functionally related gene groups, we used two complementary methods. The coordinate regulation of groups of functionally related genes has been identified in numerous studies (Wen et al., 1998; Chu et al., 1998; Eisen et al., 1998; Spellman et al., 1998; Heyer et al., 1999; Mirnics et al., 2000) . Often, the identification of such groups can provide insight into the types of cellular processes that have been perturbed in the experimental state. We first employed the DRAGON database (Bouton and Pevsner, 2000a) and its associated information visualization tools known as DRAGON View (http://pevsnerlab.kennedykrieger.org/dragonview.htm) to screen our entire Incyte data set for the coordinate regulation of functionally related genes. The two Incyte data sets, comprising 17,678 genes, were combined and annotated with SWISS-PROT database keywords using the DRAGON Database. Using the SWISS-PROT keywords, the DRAGON View analysis indicated that the tRNA synthetase and collagen families were the two largest coregulated gene groups in the entire combined data set (Fig. 5A) . In order to determine the significance of the altered expression of these two groups, we employed the default hierarchy nodes provided by GEMtools in a manner similar to that previously described (Mirnics et al., 2000) . GEMtools provided two functional classifications (tRNA charging, Table 3A and Collagens, Table 3B ) that closely matched the same gene groups identified with SWISS-PROT keywords. 2 analysis was used to determine the statistical significance of the compared distribution histograms of all genes on the two Incyte arrays against the distribution histograms of the tRNA charging and collagens groups. Both groups were calculated to have expression profiles that were significantly different from that of the combined data set (Fig. 5B) according to the strict criteria of p Ͻ 0.0001 (see Materials and Methods). Of the 250 GEMtools functional gene groups analyzed, the Amino Acid Biosynthesis gene group was the only other gene group that also displayed coordinated differential regulation according to 2 analysis ( Fig. 5B and Table 3C ). When the PvC and PvN data sets are examined independently, the tRNA synthetase and collagen families have similar coordinate expression in each (Table 3 ). The altered distribution of the tRNA synthetase and collagen families is not accounted for by the size of the family. Many other gene families of similar size such as the actins and neuropeptides (Fig. 5B ) have distributions that are not significantly different than the distribution of all genes. We tested the distribution of three other gene groups that we hypothesized might be coordinately regulated according to previous observations regarding the perturbation of gene expression patterns caused by lead. These groups were calcium transporters/channels (Calcium Transporters), Metalloproteases, and Zinc-binding transcription factors (Fig. 5B) . None of these groups demonstrated coordinated differential regulation.
Differential Gene Expression Confirmations
In order to independently confirm the results obtained from our microarray analysis, we conducted RT-PCR and Western blotting analysis of a randomly selected subset of differentially regulated genes identified by microarray analysis. These experiments were intended to demonstrate that the differential regulation of selected subsets of genes could be confirmed by independent methods. Therefore, the genes were randomly selected so as not to bias our confirmations toward genes that were previously known to be differentially regulated by lead. RT-PCR analysis performed on quadruplicate samples from each of the three different conditions confirmed the differential regulation of four genes: cytosolic phospholipase A2 (PLA2; Fig. 6A ), annexin A5 (Fig. 6B) , chloride channel 3 (CLC3; Fig. 6C ), and creatine transporter 1 (CT1; Fig.  6D ) compared to the consistent expression of GAPDH (Fig. 6E ) across all 12 samples. Western blotting performed in duplicate on independently prepared cytosolic fractions of astrocyte cell cultures confirmed the differential regulation of four different gene products. The microarray analysis corresponded with an altered level of the corresponding encoded proteins. These genes were annexin A5 (Fig. 7A), syntaxin (Fig. 7B) , annexin A1 (Fig. 7C) , and myristolated alanine-rich C kinase substrate (MARCKS, Fig. 7D ).
Annexin A5 Phospholipid Binding Assay
The differential regulation of annexin A5 by lead was detected on the Clontech microarrays ( Fig. 2C and Table 1 ). Annexin A5 is not present on the Incyte UniGEM V microarray; however, three other annexins, A1, A4, and A7, are all on the UniGEM V microarray. Of these, annexin A1 was significantly differentially regulated on both the PvC and PvN microarrays (Table 2 ) and confirmed by Western blotting (Fig.  7C) . The annexins are a family of calcium-dependent, phospholipid binding proteins involved in signal transduction and other cellular processes. These characteristics suggested that the annexins may be direct molecular targets of lead via substitution for calcium in their cation binding domains. Specifically, we hypothesized that lead promotes annexin A5 binding to phospholipid in a manner similar to its effects on the phospholipid binding characteristics of both PKC and synaptotagmin I. Therefore, we chose to study the effects of lead on annexin A5 more extensively. We first confirmed the differential regulation of annexin A5 mRNA by RT-PCR (Fig. 6B ) and annexin A5 protein by Western blotting (Fig. 7A) . We then isolated pure recombinant human annexin A5 as a thrombincleaved GST fusion protein (Fig. 8A ) for use in tritiated 75% phosphatidylcholine/25% phosphatidylserine phospholipid liposome binding assays. In the absence of annexin A5, phospholipid liposomes are not precipitated under any condition. However, upon the addition of annexin A5, significant amounts of phospholipid liposomes were precipitated in the presence of 200 M Ca 2ϩ and 10 nM Pb 2ϩ (Fig. 8B) . The binding affinity of annexin A5 to phospholipid liposomes was determined across a physiologically relevant concentration range of lead (Fig. 8C) . Statistically significant binding effects were observed at lead concentrations as low as ϳ8 nM. A halfmaximal binding concentration of ϳ30 nM lead was observed for the binding of annexin A5 to phospholipid liposomes, with a saturating concentration of ϳ100 nM.
DISCUSSION
Clustering Methods
A central tenet in the field of toxicogenomics is that specific toxicant "signatures" can be detected through the use of largescale genome-based technologies such as microarrays . These signatures consist of the observation of genome-wide patterns of gene expression in response to treatment of a specific cell or tissue type with a toxicant Rockett and Dix, 1999) . One aim of signature identification is the classification of known toxicants into categories based upon specific gene expression patterns in specific tissue types. This library of signatures could then be used to rapidly and inexpensively screen novel drug candidates (Marton et al., 1998; Wilson et al., 1999) or suspected toxicants for similarities to known toxicants. To date, a few studies have demonstrated the ability to identify toxicant signatures through microarray analysis (Gasch et al., 2000; Burczynski et al., 
FIG. 5. (A)
The DRAGON database was used to annotate all 17,678 genes analyzed on two Incyte microarrays with SWISS-PROT keyword information. The DRAGON Families information visualization tool was then used to visualize the ratio expression values of each keyword category across the entire data set. This analysis was used to identify groups of biologically related genes that are coordinately regulated. In the entire Incyte data set, one family (Aminoacyl-tRNA synthetase) was significantly, differentially up-regulated by lead treatment and one was found to be significantly down-regulated (Collagen) according to the criteria described under Results. Other families that were coordinately regulated but did not meet the criteria are also shown. The average expression value for each family is displayed in parentheses (blue text) to the right of each family. (B) The significance of the differential regulation of these two families was further investigated by comparing the distribution of all 17,678 gene expression values versus each gene family as defined by the "default hierarchy nodes" provided by GEMtools. Only three such families were found to have significantly altered distributions: tRNA synthetases and Exportin, Amino Acid Biosynthesis, and Collagens. The gray bars in each graph display the distribution of all gene expression values as shown in All Genes. The colored bars in each graph display the distribution of all of the genes in that family (e.g., Amino Acid Biosynthesis), the number in parentheses provides the number of genes in that family (e.g., n ϭ 57), and the p values indicate the probability of a given distribution happening by chance as determined by 2 analysis. Significant p values ( p Ͻ 0.0001) are displayed in red. 2000). We suggest that we have done so with lead in astrocyte cell cultures. Our ability to distinguish lead versus control and sodium samples purely through the clustering of microarray data is an example of the detection and use of a signature derived from gene expression data in order to identify toxicantversus nontoxicant-treated cells. Results from our clustering analysis indicate that lead treatment of astrocyte cell cultures can induce a pattern of gene expression that is distinct from the normal profile of gene expression in that cell type. This pattern was consistent across four independent replicates of the leadexposed cell cultures. However, we are not able to conclude whether the signature induced by lead is different from a signature that might be induced by other heavy metals (e.g., cadmium or mercury) or other nonmetal toxicants (e.g., pesticides). In order to conclude this, further microarray research comparing the pattern of gene expression induced by numerous toxicants is required. Furthermore, the signature we have identified in our studies is specific to astrocyte cell cultures and would presumably be partially or completely different in other cell cultures or tissue samples. Further studies are required to assess how similar the lead signature is across different species, tissues, developmental stages, lead concentrations, and time courses.
The distinct pattern of gene expression induced by lead and detected by our clustering methods is composed of the altered regulation of numerous specific genes. Many of these genes can be categorized into groups based upon shared properties.
Stress Response Genes
Of those genes found to be up-regulated by lead treatment on the Clontech microarrays, GFAP, microsomal glutathione Stransferase, mitochondrial 10-kDa heat shock protein, and HSP70 are all involved in general cellular responses to stress. In addition to VEGF (discussed below), a couple of these genes provide proof of principle for our microarray data. Specifically, both GFAP and HSP70 have both been previously reported to be differentially regulated by lead treatment. GFAP was found to be down-regulated in lead-treated astrocytes on both the Clontech and Incyte microarrays. On the Clontech Neuroarrays the lead versus control ratio was Ϫ1.8 with a t test p value of 0.00065 and the lead versus sodium ratio was Ϫ1.6 with a t test p value of 0.00032. On the Incyte microarray, while GFAP was found to be down-regulated, the degree of down-regulation was not as high. In the lead versus control samples, GFAP was down-regulated by a ratio of Ϫ1.3 and in the lead versus sodium samples it was down-regulated by a ratio of Ϫ1.1. Previous studies have reported the up-regulation (Stoltenburg et al., 1996) , down-regulation , and altered regulation of GFAP following lead treatment in a range of tissues. HSP70 was differentially regulated on the Incyte arrays where it was represented by two different "spots" that were both among the top five most differentially regulated genes (HSP70 was not represented on Note. The regulation of each gene (name and Genbank no.) in a given family had similar expression levels on the lead versus control (PvC) and lead versus sodium (PvN) Incyte microarrays. All of the genes in the tRNA synthetases and Collagen families are shown. A subset of all genes in the Amino Acid Biosynthesis family is shown due to the size of the family. Genes that were down-regulated in lead-treated astrocytes are displayed with their ratio expression values with a grey background; genes that were up-regulated in leadtreated astrocytes have ratio expression values with a white background.
the Clontech Neuroarrays). Altered levels of both HSP70 mRNA and protein have been detected in numerous previous studies (Selvin-Testa et al., 1997; Witzmann et al., 1999; Tully et al., 2000) . Another GST-related gene, Glutathione S-transferase like, was differentially regulated on the Incyte microarrays. All of these genes are found to be differentially regulated in response to a range of different cellular stressors, including UV irradiation, heat shock, other metal toxicants, and nonmetal toxicants. Therefore, the detection of the differential regulation of these genes on our microarrays suggests that the lead treatment we performed induces a general cellular stress response in astrocytes.
Genes Encoding Calcium Binding Proteins
Numerous genes encoding calcium binding proteins were differentially regulated by lead treatment including Ca 2ϩ /calmodulin-activated adenlyl cyclase (Mons et al., 1998) , annexin A1, annexin A5, sorcin 22-kDa protein (Maki et al., 1997; Brownawell and Creutz, 1997) , calcineurin B subunit isoform 1, caldesmon 1, calmodulin-related protein NB-1, and two phospholipase A2 isoforms. Alteration of the transcriptional expression of genes that encode calcium binding proteins could be due to either indirect effects of lead on regulators of gene transcription (e.g., PKC or zinc-finger DNA binding proteins) or to the activation of regulatory feedback loops due to the direct binding of lead to calcium binding proteins. Our data do not allow us to distinguish between these two possible mechanisms.
Of the numerous differentially regulated genes known to encode calcium binding proteins, a few are particularly noteworthy. First, the phospholipase A2s are a family of C2-domain containing calcium-dependent phospholipid binding proteins. Lead has been previously shown to bind to the calcium binding C2 domain of synaptotagmin I (Bouton et al., 2001) . Therefore, it is possible that lead may also directly bind FIG. 6. Semiquantitative RT-PCR was used to confirm the differential regulation of four genes (phospholipase A2, PLA2; annexin A5; chloride channel 3, CLC3; and creatine transporter 1, CT1) compared to a nonregulated gene (glyceraldehyde-3-phosphate dehydrogenase, GAPDH) initially identified by Clontech and Incyte microarray analysis. Confirmations were performed in quadruplicate using cDNA samples from lead-, control-, and sodium-treated astrocytes. A primer control (PC) was run during each reaction in order to demonstrate specificity of the product. Band intensities were measured using Scion Image analysis software, normalized against corresponding GAPDH bands and averaged. Bar graphs to the right of each set of bands display average normalized values in addition to the standard deviation for each value. *Significant Student's t test value ( p Ͻ 0.05) between lead and either control or sodium values. **Significant difference between lead and both of the other conditions. Results are typical of experiment performed three independent times, each time in quadruplicate.
FIG. 7.
Western blotting for four different proteins (annexin 1, annexin 5, syntaxin, and MARCKS) found to be differentially regulated at the RNA level by Clontech and Incyte microarray analysis. Western blots were conducted using detergent-solubilized, cytosolic cellular fractions of lead-versus sodiumtreated astrocyte cell cultures. Samples were analyzed in duplicate. Band intensities were measured using Scion Image image analysis software, normalized to band intensities derived from Ponceau S staining (see Materials and Methods), averaged, and graphed to the right of each set of bands along with error bars representing standard deviation. Results are typical of an experiment performed three independent times, each time in duplicate.
to PLA2 isoforms via their C2 domains. Previous studies have demonstrated either a direct activation of PLA2 by lead in vitro (Krug and Berndt, 1987; Krug et al., 1994) or a ionophoredependent activation of PLA2 by lead (Bressler et al., 1994) as measured by increases in free arachidonic acid. Recently, Osterode and Ulberth (2000) demonstrated increased concentrations of arachidonic acid in the red blood cells (RBC) of 12 lead-exposed adult men compared to 12 healthy, unexposed,
FIG. 8. (A)
His-tagged annexin A5 (ϳ35 kDa) was initially acquired from the laboratory of Dr. Mark Schlissel. This clone was used to produce a GST fusion of annexin A5 (ϳ60 kDa) that was then thrombin-cleaved in order to obtain pure, unfused annexin A5 protein (ϳ35 kDa). (B) Phospholipid binding reactions were carried out in the presence or absence of annexin A5 protein under three different cation conditions: no cation (1 mM NTA), calcium (200 M Ca 2ϩ ), or lead (10 nM Pb 2ϩ ). Tritiated phospholipid scintillation counts were normalized as described under Materials and Methods. *Student's t test p Ͻ 0.05 for either calcium or lead condition versus no cation condition. Error bars indicate standard deviation. Results are typical of experiment performed three independent times, each time in triplicate. (C) Phospholipid binding reactions were carried out across a range of physiologically relevant free lead concentrations. The curve was fit to the data as described under Materials and Methods. An EC50 of ϳ30 nM was calculated for lead-dependent binding of annexin A5 to phospholipid liposomes. Error bars indicate standard deviation. Results are typical of experiment performed three independent times, each time in triplicate. age-matched adult men, suggesting that the effects of lead on PLA2 can also occur in vivo in lead-exposed humans. The increases in arachidonic acid in the RBCs of the lead-exposed men were directly correlated with the concentration of lead in the blood of each individual.
Second, the annexin A5 gene, which encodes a calciumdependent phospholipid binding protein (Meers et al., 1991; Kohler et al., 1997) , was differentially regulated by lead. We hypothesized that the annexin A5 protein might be a direct molecular target of lead based upon previous data showing that lead binds to other calcium-dependent phospholipid binding proteins such as PKC and synaptotagmin I. Most members of the annexin protein family contain four repeated domains that bind negatively charged phospholipids in a calcium-dependent manner. We used biochemical methods to demonstrate that nanomolar concentrations of lead can induce the phospholipid binding activity of annexin A5. These experiments suggest that lead does bind annexin A5 directly. Further studies are required in order to evaluate the role of the lead-induced phospholipid binding of annexin A5 within the context of the overall effects of lead in cellular systems.
Although the functions of the annexins have not been fully elucidated, it seems that many are involved in signal transduction cascades and neuronal activity regulation. Annexin A5 has been shown to be a potent inhibitor of PKC activity (Schlaepfer et al., 1992; Shibata et al., 1992; Dubois et al., 1996) . Some studies have reported that the inhibition of PKC by annexin A5 occurs through a direct interaction (Schlaepfer et al., 1992) . Other studies have reported that inhibition occurs primarily through the competition of annexin A5 and PKC for phospholipid binding during calcium-dependent activation (Dubois et al., 1998) . Our findings, when considered in the context of this previous literature, suggest that the lead-dependent activation of annexin A5 binding to phospholipid liposomes may resemble the cellular effects of lead-dependent PKC activation.
Finally, Markovac and Goldstein (1988) previously demonstrated the activation of the calcium-binding protein PKC by picomolar concentrations of lead via the PKC C2 domain. Numerous subsequent studies have confirmed the alteration of PKC-dependent cellular systems by lead treatment. Alteration of PKC activity by the direct binding of lead to PKC can cause the altered transcriptional regulation of various genes. This may also occur because PKC aberrantly phosphorylates the protein products of these genes, leading to the altered protein activity and subsequent feedback regulation of the protein's mRNA transcript. Our microarray results suggest that both types of PKC-dependent gene regulation may be occurring due to lead exposure. For example, numerous genes, the protein products of which are known to be phosphorylated by PKC, were found to be differentially regulated by lead in our microarray data. Examples include MARCKS (Albert et al., 1986; Aderem, 1992) , chloride channel 3 (CLC3; Duan et al., 1999) , histidine decarboxylase (Hocker et al., 1996) , and annexin A1. Alternatively, Hossain et al. (2000) reported the PKC-dependent regulation of the VEGF gene by lead treatment. They demonstrated that differential VEGF gene expression occurred due to the altered ability of PKC to transcriptionally regulate VEGF mRNA production.
Angiogenesis and Blood-Brain Barrier-Related Genes
Astrocytes participate in the formation of the blood-brain barrier. Lead can cause significant disruptions in blood-brain barrier formation, especially in young children. As previously discussed, due to the role of VEGF in angiogenesis and the maintenance of the blood-brain barrier, the differential regulation of VEGF by lead implicated VEGF in the microvasculopathy associated with lead encephalopathy. In the extended list of lead-altered genes identified in our study, three other differentially regulated genes were identified that might also be involved in the lead-induced disruption of the blood-brain barrier. First, the VEGF receptor Vascular endothelial growth factor receptor 3 precursor (Table 1 ) was found to be upregulated on the Clontech microarrays. Second, thrombospondin 2, down-regulated on the Incyte microarrays (Table  2) , is a potent inhibitor of angiogenesis that opposes the angiogenic activity of VEGF isoforms in skin and tumor vascularization Kazuno et al., 1999; Streit et al., 1999; Detmar, 2000a,b) . Finally, ephrin receptors were found to be differentially regulated by lead. Ephrin type-B receptor 3 precursor was down-regulated and ephrin type-A receptor 2 precursor was up-regulated on the Clontech microarrays (Table 1 ). The ephrin receptors have been previously shown to be involved in the adhesive response of endothelial cells and the remodeling of blood vessels (Wilkinson, 2000) .
The extracellular matrix is critical to the integrity of the blood-brain barrier. We identified the lead-induced altered regulation of a large number of collagen genes in astrocytes within the context of the expression patterns of ϳ9000 other genes. The collagen genes were the only family of genes that were found to be coordinately down-regulated by lead and some of the collagen genes were among the most downregulated genes identified (Table 3) . These results indicate that acute low-level lead treatment has significant effects on the regulation of collagen genes as a group in astrocytes. Leadinduced alteration of collagen biosynthesis in astrocytes has potential implications for the effects of lead on the blood-brain barrier as suggested by previous studies (Rodolfo-Sioson and Ahrens, 1980) . Effects of lead on collagen biosynthesis have also been studied in relation to rheumatoid arthritis (Goldberg et al., 1983) , skeletal abnormalities (Pounds et al., 1991; Klein and Wiren, 1993; Hicks et al., 1996) , and lead-based skin ointments (Vandeputte et al., 1990) . One of the major sites of lead storage in the body is in bone. Lead is incorporated into bone during the calcification of cartilage (Hicks et al., 1996) and can cause abberrant calcification of cartilaginous areas if injected subcutaneously (Ellender and Ham, 1987; Vandeputte et al., 1990) . Cartilage is made primarily of collagen. Lead also binds to collagen (Miksik et al., 1999) . Previous studies have demonstrated lead-induced alterations in collagen biosynthesis at both the mRNA and protein level in vitro (Vistica et al., 1977; Goldberg et al., 1983; Long and Rosen, 1992; Klein and Wiren, 1993; Hicks et al., 1996) and in vivo (Rodolfo-Sisoson and Ahrens, 1980; Rana and Prakash, 1986; Ahrens, 1993) . The effects of lead on collagen biosynthesis have been linked to calcium-dependent signaling pathways that include PKC and EGF (Pounds et al., 1991; Long and Rosen, 1992) .
Amino Acid Biosynthesis and tRNA Synthetases
Studies five decades ago first reported the cleavage of ribonucleic acids by lead (Dimroth et al., 1950; Farkas, 1968) . Since then, lead has been routinely used as a tool for the study of the secondary structure of tRNA (Krebs et al., 1972; Farkas et al., 1972; Pan et al., 1994; Otzen et al., 1994; Ciesiolka et al., 1998; Perreau et al., 1999) , mRNA (Farkas, 1975) , and rRNA molecules (Winter et al., 1997) . Lead is capable of cleaving RNA at specific sites through a mechanism of nucleophilic attack (Brown et al., 1983) . Low micromolar concentrations of lead can cause RNA cleavage (Werner et al., 1976) . Lead-induced RNA cleavage can occur both in vitro and in vivo (Kennedy et al., 1983) . Under physiological conditions (pH 7.4 and 37°C) lead is 28 times more potent than the next most effective divalent cation, zinc, in cleaving RNA (Farkas, 1968; Otzen et al., 1994) . Kennedy et al. (1983) prepared postmitochondrial fractions from the brains of rat pups treated with 4% lead carbonate maternal milk for 2 days. Lead-exposed fractions displayed significantly lower amounts of protein synthesis activity than controls. A significant reduction in the level of tRNA synthetase activity accounted for most of the reduction in protein synthesis activity. Our microarray results, when analyzed in relation to previous findings, indicate that the protein synthesis machinery is a target of lead treatment. This is suggested by the coordinate differential regulation of the amino acid biosynthesis-related genes (Table 3) . Furthermore, it seems that tRNA synthetase activity in particular is disrupted by lead and that this ability to cleave tRNA molecules may be the cause of these disruptions. A reduction in the amount of tRNA available for the tRNA synthetases would cause a reduction in the synthase activity and thus impair protein synthesis. Exportin-t is the major nuclear exporter of tRNA molecules (Arts et al., 1998a,b; Kutay et al., 1998; Lipowsky et al., 1999; Grosshans et al., 2000) and was also found to be significantly up-regulated in lead-treated astrocytes.
Conclusions
We have employed cDNA microarrays to simultaneously detect the expression levels of ϳ10,000 genes in lead-exposed astrocytes. The data generated from this analysis allowed for observations regarding the effects of lead on gene expression patterns and the identification of several novel in vitro molecular targets of lead. First, using established clustering methods, we have demonstrated the ability to differentiate between leadexposed versus two types of control-treated cells solely on the basis of gene expression patterns. This indicates that lead can induce a distinct pattern of gene expression in astrocytes. Second, as proof of principle, we have identified genes previously shown to be differentially regulated by lead. Third, we have identified novel putative targets of lead and have discussed the implications of these findings in relation to previous literature concerning the cellular effects of lead. Finally, based upon our microarray data, we hypothesized that a specific gene product, annexin A5 protein, may be a direct molecular target of lead. Subsequent biochemical studies demonstrated that lead induces the phospholipid binding of annexin A5 at nanomolar concentrations. Annexin A5 phospholipid binding is normally induced by calcium at micromolar concentrations. Therefore, lead is capable of disrupting the normal phospholipid binding characteristics of annexin A5 in a manner similar to its effects on both PKC and synaptotagmin I.
We suggest that endogenous cation substitution is a central mechanism of lead toxicity. Alteration of the normal activity of both calcium and zinc binding proteins can cause a variety of molecular and cellular perturbations, including disruptions in normal gene expression patterns as we have reported herein. These lead-induced dysfunctions presumably manifest as clinical features upon sufficiently high levels of lead exposure. Future studies analyzing the gene expression profiles induced by lead versus other metal and nonmetal toxicants may allow for the further identification of similarities and differences caused by various toxicants.
